Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
PCC0208017
AOB11167
CAS: 85822-93-1
Chemical Name: N4-((1H-Pyrazol-3-yl)methyl)-N2-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5-(trifluoromethyl)pyrimidine-2,4-diamine
1993 Items
Quantity Discount Table - Order More To Get More Price Discount
| Quantity (mg or Unit) | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|
| 5 | $58.65 | Total: $293.25 |
| 10 | $49.68 | Total: $496.80 |
| 25 | $42.09 | Total: $1,052.25 |
| 50 | $35.88 | Total: $1,794.00 |
| 100 | $31.05 | Total: $3,105.00 |
Overview
Novel Inhibitor of MARK3/MARK4, Suppressing Glioma Progression in vitro and in vivo
Chemical Properties
| Molecular Formula | C19H20F3N7 |
| Molecular Weight | 403.41 |
| CAS Numbers | 2623158-64-3 |
| Solubility | DMSO and Alcohol |
| Purity | 98% by HPLC |
| IUPAC/Chemical Name | N4-((1H-Pyrazol-3-yl)methyl)-N2-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-5-(trifluoromethyl)pyrimidine-2,4-diamine |
| InChl Key | PIESSZHWYCPHQD-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C19H20F3N7/c1-29-7-5-12-8-14(3-2-13(12)11-29)26-18-24-10-16(19(20,21)22)17(27-18)23-9-15-4-6-25-28-15/h2-4,6,8,10H,5,7,9,11H2,1H3,(H,25,28)(H2,23,24,26,27) |
| SMILES Code | FC(C1=CN=C(NC2=CC3=C(CN(C)CC3)C=C2)N=C1NCC4=NNC=C4)(F)F |
Storage and Handling
0°C (short term), -20°C (long term), desiccated
Synonyms
PCC0208017; PCC-0208017; PCC 0208017;
References
1) FangfangLi et al., PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo, Acta Pharmaceutica Sinica B Volume 10, Issue 2, February 2020, Pages 289-300
Customers who bought this product also bought:
-
$32.50
-
$89.70
-
$76.70
-
$13.00
-
$27.30
